Evidence map›Paper›PMID 30153805›Full record

ArticleBMC gastroenterology2018

Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.

Jillian R-M Brown, Burkhardt Flemer, Susan A Joyce, Akbar Zulquernain, Donal Sheehan, Fergus Shanahan, Paul W O'Toole

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 96 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Article
  11. Article
  12. Food as Medicine for Hypertension: Microbiota as Mediators.Hypertension (Dallas, Tex. : 1979) · 2025
    Review
  13. Fecal Metabolomics for the Diagnosis ofDiagnostics (Basel, Switzerland) · 2025
    Article
  14. Review
  15. Review
  16. Review
  17. Advances in Fecal Microbiota Transplantation for Gut Dysbiosis-Related Diseases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  18. Article
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jillian R-M BrownAPC Microbiome Institute, University College Cork, National University of Ireland, Cork, Ireland.
Burkhardt FlemerAPC Microbiome Institute, University College Cork, National University of Ireland, Cork, Ireland.
Susan A JoyceAPC Microbiome Institute, University College Cork, National University of Ireland, Cork, Ireland.
Akbar ZulquernainAPC Microbiome Institute, University College Cork, National University of Ireland, Cork, Ireland.
Donal SheehanAPC Microbiome Institute, University College Cork, National University of Ireland, Cork, Ireland.
Fergus ShanahanAPC Microbiome Institute, University College Cork, National University of Ireland, Cork, Ireland.
Paul W O'TooleAPC Microbiome Institute, University College Cork, National University of Ireland, Cork, Ireland. pwotoole@ucc.ie.
University College Cork · IEAPC Microbiome Institute · IENational University of Ireland · IE

Funding

Science Foundation Ireland (SFI/12/RC/2273)Science Foundation Ireland SFI/12/RC/2273
6 · The paper itself

Abstract

backgroundAlteration of the gut microbiota by repeated antibiotic treatment increases susceptibility to Clostridioides difficile infection. Faecal microbiota transplantation from donors with a normal microbiota effectively treats C. difficile infection.

methodsThe study involved 10 patients with recurrent C. difficile infection, nine of whom received transplants from individual donors and one who received a donor unit from a stool bank (OpenBiome).

resultsAll individuals demonstrated enduring post-transplant resolution of C. difficile- associated diarrhoea. Faecal microbiota diversity of recipients significantly increased, and the composition of the microbiota resembled that of the donor. Patients with C. difficile infection exhibited significantly lower faecal levels of secondary/ bile acids and higher levels of primary bile acids. Levels of secondary bile acids were restored in all transplant recipients, but to a lower degree with the OpenBiome transplant. The abundance increased of bacterial genera known from previous studies to confer resistance to growth and germination of C. difficile. These were significantly negatively associated with primary bile acid levels and positively related with secondary bile acid levels. Although reduced levels of the short chain fatty acids, butyrate, propionate and acetate, have been previously reported, here we report elevations in SCFA, pyruvic and lactic fatty acids, saturated, ω-6, monounsaturated, ω-3 and ω-6 polyunsaturated fatty acids (PUFA) in C. difficile infection. This potentially indicates one or a combination of increased dietary FA intake, microbial modification of FAs or epithelial cell damage and inflammatory cell recruitment. No reversion to donor FA profile occurred post-FMT but ω-3 to ω-6 PUFA ratios were altered in the direction of the donor. Archaeal metabolism genes were found in some samples post FMT.

conclusionA consistent metabolic signature was identified in the post-transplant microbiota, with reduced primary bile acids and substantial restoration of secondary bile acid production capacity. Total FA levels were unchanged but the ratio of inflammatory to non-inflammatory FAs decreased.

Indexed as

Clostridioides difficileFecal Microbiota TransplantationGastrointestinal MicrobiomeAdultAgedAged, 80 and overBile Acids and SaltsClostridium InfectionsFatty Acids, VolatileFecesFemaleHumansMaleMiddle AgedRecurrenceYoung AdultBile Acids and SaltsFatty Acids, VolatileArchaeaBile acidsClostridioides difficileFaecal microbiota transplantationFatty acids

Identifiers

PMID30153805
PMCPMC6114236
OpenAlexW2889477263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.